M&A Deal Summary |
|
|---|---|
| Date | 2021-06-17 |
| Target | OPKO Health - Sterile Fill & Finish Manufacturing Facility |
| Sector | Life Science |
| Buyer(s) | Horizon Therapeutics |
| Sellers(s) | Opko |
| Deal Type | Divestiture |
| Deal Value | 65M USD |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 2005 |
| Sector | Life Science |
| Employees | 2,100 |
| Revenue | 3.2B USD (2021) |
Horizon Therapeutics is a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The Company markets seven medicines through its orphan, primary care and specialty business units. Horizon Therapeutics was founded in 2005 and is based in Dublin, Ireland.
| DEAL STATS | # |
|---|---|
| Overall | 11 of 11 |
| Sector (Life Science) | 11 of 11 |
| Type (Divestiture) | 4 of 4 |
| Country (Ireland) | 1 of 1 |
| Year (2021) | 2 of 2 |
| Size (of disclosed) | 7 of 10 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-02-01 |
Viela Bio
Gaithersburg, Maryland, United States Viela Bio is dedicated to the development and commercialization of novel, life-changing medicines for patients with a wide range of autoimmune and severe inflammatory diseases. Viela Bio was founded in 2018 and is based in Gaithersburg, United States. |
Buy | $3.1B |
| Category | Company |
|---|---|
| Founded | 1991 |
| Sector | Life Science |
| Employees | 3,930 |
| Revenue | 863M USD (2023) |
Opko is a diversified healthcare company with a focus on establishing leading positions in significant and rapidly growing medical markets. Opko's operations are divided into diagnostics and pharmaceuticals, each with specialized products and services aimed at improving patient care and outcomes. Opko was founded in 1991 and is based in Miami, Florida.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 3 |
| Sector (Life Science) | 2 of 2 |
| Type (Divestiture) | 3 of 3 |
| Country (Ireland) | 1 of 1 |
| Year (2021) | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-02-17 |
CareEvolve
Elmwood Park, New Jersey, United States CareEvolve is a provider of internet based order entry and results reporting solutions for laboratory, pathology and radiology outreach businesses. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-05-09 |
ModeX Therapeutics
Natick, Massachusetts, United States ModeX Therapeutics has developed highly flexible multi-specific antibody technology platforms with broad targeting and functional capabilities, simpler manufacturing, and potentially better specificity and safety, providing significant differentiation from competing platforms. ModeX Therapeutics was founded in October 2020 with headquarters in Natick, Massachusetts. |
Buy | $300M |
